CD33 and colorectal carcinoma: Additionally, multiple IF of clinical CRC samples further validated that CXCL3 was negatively correlated with CD8+ T cells but positively correlated with CD33+ CD11b+ MDSC cells in tumors (Figure 8, G–K).